Chi Meng
Impact in
- Pharmacology top 10%
- Piperaceae Chemical and Biological Studies
- Toxicology top 10%
Papers in
-
- Histone Deacetylase Inhibitors Research 6
- Protein Degradation and Inhibitors 3
- Phytochemical compounds biological activities 3
-
- Nanoplatforms for cancer theranostics 12
- Co-authors
- Yong Ling (22 shared papers)Jianqiang Qian (17 shared papers)Zhongyuan Xu (12 shared papers)Peng Zhu (9 shared papers)Fude Feng (3 shared papers)Jinlei Peng (2 shared papers)Chang‐Chun Ling (8 shared papers)Weizhong Zhu (5 shared papers)
- Journals
- European Journal of Medicinal Chemistry (5 papers)Journal of Natural Products (3 papers)Journal of Medicinal Chemistry (2 papers)Molecules (2 papers)Theranostics (2 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Chi Meng
27 papers receiving 587 citations
Peers
Comparison fields: 5 of 79
- Pharmacology 54
- Toxicology 18
- Organic Chemistry 157
- Biochemistry 30
- Biomaterials 51
Countries citing papers authored by Chi Meng
This map shows the geographic impact of Chi Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Meng more than expected).
Fields of papers citing papers by Chi Meng
This network shows the impact of papers produced by Chi Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Meng. The network helps show where Chi Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Chi Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 70 | |
| 2 | 2019 | 54 | |
| 3 | 2021 | 49 | |
| 4 | 2020 | 40 | |
| 5 | 2019 | 39 | |
| 6 | 2019 | 37 | |
| 7 | 2020 | 32 | |
| 8 | 2020 | 27 | |
| 9 | 2020 | 26 | |
| 10 | 2021 | 24 | |
| 11 | 2022 | 23 | |
| 12 | 2021 | 20 | |
| 13 | 2023 | 19 | |
| 14 | 2022 | 16 | |
| 15 | 2021 | 15 | |
| 16 | 2022 | 14 | |
| 17 | 2021 | 13 | |
| 18 | 2020 | 13 | |
| 19 | 2021 | 10 | |
| 20 | 2024 | 9 |
About Chi Meng
Chi Meng is a scholar working on Molecular Biology, Biomedical Engineering, Pharmacology, Materials Chemistry and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 593 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (12 papers), Piperaceae Chemical and Biological Studies (6 papers), Histone Deacetylase Inhibitors Research (6 papers), Photodynamic Therapy Research Studies (4 papers), Luminescence and Fluorescent Materials (4 papers), Protein Degradation and Inhibitors (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Phytochemical compounds biological activities (3 papers). The work is most often cited by research in Pharmacology (54 citations), Toxicology (18 citations), Organic Chemistry (157 citations), Biochemistry (30 citations) and Biomaterials (51 citations). Chi Meng has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Yong Ling, Jianqiang Qian, Zhongyuan Xu, Peng Zhu, Fude Feng, Jinlei Peng, Chang‐Chun Ling, Weizhong Zhu, Yanan Zhang and Weijie Gao. Their work appears in journals such as European Journal of Medicinal Chemistry, Journal of Natural Products, Journal of Medicinal Chemistry, Molecules and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.